http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014283185-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35dbc60da9891d57c4047fb7b8689516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d190ff62e7e6bdccf09ebe38a6d85c2f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6801
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2014-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f8bc2c2f5478d156b5163a54148ed99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a25b62a89ac5d478281d25c786023ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf2cec82e2a2b8c2ec37fa05db59a2a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5ceb96a87c6cf013bbf62b1da6d705a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b42e604375972cd17d66aa751e59db32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff74917fdf17f49405710c8396c6fe8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a8ff3a14e1730893e8a07d8e55b4fde
publicationDate 2019-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2014283185-B2
titleOfInvention Enzymatic conjugation of polypeptides
abstract The present application relates to methods for the enzymatic functionalization of immunoglobulins, in particular with drugs. Also disclosed herein are linking reagents, functionalized antibodies, pharmaceutical compositions, and method of treating disease and/or conditions.
priorityDate 2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013122020-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005070468-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465460159
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466252259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86580391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412615308
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163772771

Total number of triples: 35.